Emergency department mortality: Fair and square.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
06 2019
Historique:
received: 05 06 2018
revised: 29 07 2018
accepted: 13 08 2018
pubmed: 20 8 2018
medline: 30 1 2020
entrez: 20 8 2018
Statut: ppublish

Résumé

This study explored the therapeutic approaches used for end-of-life (EOL) patients admitted to the emergency department (ED) and examined whether the decision to perform life-extending treatment (LET) or to allow natural death (AND) depends on patient characteristics, medical staff variables, and ED setting. A retrospective archive study was conducted from January 2015 to December 2017 in the ED of a tertiary hospital. The study sample were 674 EOL patients who had died in the ED. For each patient, data were collected and measured for dying process (LET vs. AND), patient characteristics, ED-setting variables, and medical-staff characteristics. The proportion of EOL patients undergoing LET increased from 18.1% in 2015 to 25.9% in 2016 and to 30.3% in 2017 (p = .010), and a quarter of them were treated by emergency medical services. Males tended to receive LET more than females (p < .001). An association was found between Jewish physicians and nurses and AND (p = .001). Heavier workload in the ED and greater severity of the triage classification predicted more LET (OR-1.67, CI = 1.05-1.76, p = .003 and OR = 1.42, CI-0.60-0.81, p < .001, respectively). Receiver operating characteristic analysis showed that patient characteristics contributed most crucially to the therapeutic approaches (C statistic 0.624-0.675, CI-0.62-0.71). The therapeutic approach used for EOL patients in the ED depends on variables in all three treatment layers: patient, medical staff, and ED setting. Applicable national programs should be developed to ensure that no external factors influence the dying-process decision.

Identifiants

pubmed: 30121156
pii: S0735-6757(18)30671-5
doi: 10.1016/j.ajem.2018.08.036
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1020-1024

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

M Saban (M)

The Cheryl Spencer Department of Nursing, University of Haifa, Israel; Rambam Health Care Campus, Haifa, Israel. Electronic address: msaban1@univ.haifa.ac.il.

H Patito (H)

The Cheryl Spencer Department of Nursing, University of Haifa, Israel; Rambam Health Care Campus, Haifa, Israel.

L Zaretsky (L)

The Cheryl Spencer Department of Nursing, University of Haifa, Israel; Rambam Health Care Campus, Haifa, Israel.

R Salama (R)

Rambam Health Care Campus, Haifa, Israel.

A Darawsha (A)

Rambam Health Care Campus, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH